抗菌剂与临床上重要的药代动力学药物相互作用。

A Torrent Rodríguez, A Font I Barceló, M Barrantes González, D Echeverria Esnal, D Soy Muner, J A Martínez, M Tuset Creus
{"title":"抗菌剂与临床上重要的药代动力学药物相互作用。","authors":"A Torrent Rodríguez, A Font I Barceló, M Barrantes González, D Echeverria Esnal, D Soy Muner, J A Martínez, M Tuset Creus","doi":"10.37201/req/037.2024","DOIUrl":null,"url":null,"abstract":"<p><p>Antimicrobial agents are widely used, and drug interactions are challenging due to increased risk of adverse effects or reduced efficacy. Among the interactions, the most important are those affecting metabolism, although those involving drug transporters are becoming increasingly known. To make clinical decisions, it is key to know the intensity of the interaction, as well as its duration and time-dependent recovery after discontinuation of the causative agents. It is not only important to be aware of all patient treatments, but also of supplements and natural medications that may also interact. Although they can have serious consequences, most interactions can be adequately managed with a good understanding of them. Especially in patients with polipharmacy it is compulsory to check them with an electronic clinical decision support database. This article aims to conduct a narrative review focusing on the major clinically significant pharmacokinetic drug-drug interactions that can be seen in patients receiving treatment for bacterial infections.</p>","PeriodicalId":94198,"journal":{"name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","volume":" ","pages":"299-322"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11231487/pdf/","citationCount":"0","resultStr":"{\"title\":\"Clinically important pharmacokinetic drug-drug interactions with antibacterial agents.\",\"authors\":\"A Torrent Rodríguez, A Font I Barceló, M Barrantes González, D Echeverria Esnal, D Soy Muner, J A Martínez, M Tuset Creus\",\"doi\":\"10.37201/req/037.2024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Antimicrobial agents are widely used, and drug interactions are challenging due to increased risk of adverse effects or reduced efficacy. Among the interactions, the most important are those affecting metabolism, although those involving drug transporters are becoming increasingly known. To make clinical decisions, it is key to know the intensity of the interaction, as well as its duration and time-dependent recovery after discontinuation of the causative agents. It is not only important to be aware of all patient treatments, but also of supplements and natural medications that may also interact. Although they can have serious consequences, most interactions can be adequately managed with a good understanding of them. Especially in patients with polipharmacy it is compulsory to check them with an electronic clinical decision support database. This article aims to conduct a narrative review focusing on the major clinically significant pharmacokinetic drug-drug interactions that can be seen in patients receiving treatment for bacterial infections.</p>\",\"PeriodicalId\":94198,\"journal\":{\"name\":\"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia\",\"volume\":\" \",\"pages\":\"299-322\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11231487/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37201/req/037.2024\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37201/req/037.2024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

抗菌药物被广泛使用,药物相互作用会增加不良反应风险或降低疗效,因此具有挑战性。在这些相互作用中,最重要的是影响新陈代谢的相互作用,尽管涉及药物转运体的相互作用也日益为人所知。要做出临床决策,关键是要了解相互作用的强度、持续时间以及停用致病药物后随时间变化的恢复情况。不仅要了解患者的所有治疗方法,还要了解可能发生相互作用的补充剂和天然药物。虽然它们可能会造成严重后果,但只要充分了解这些相互作用,大多数情况下都能得到妥善处理。特别是对于多药合用的患者,必须通过电子临床决策支持数据库进行检查。本文旨在对接受细菌感染治疗的患者中可能出现的具有重大临床意义的药代动力学药物间相互作用进行叙述性综述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Clinically important pharmacokinetic drug-drug interactions with antibacterial agents.

Antimicrobial agents are widely used, and drug interactions are challenging due to increased risk of adverse effects or reduced efficacy. Among the interactions, the most important are those affecting metabolism, although those involving drug transporters are becoming increasingly known. To make clinical decisions, it is key to know the intensity of the interaction, as well as its duration and time-dependent recovery after discontinuation of the causative agents. It is not only important to be aware of all patient treatments, but also of supplements and natural medications that may also interact. Although they can have serious consequences, most interactions can be adequately managed with a good understanding of them. Especially in patients with polipharmacy it is compulsory to check them with an electronic clinical decision support database. This article aims to conduct a narrative review focusing on the major clinically significant pharmacokinetic drug-drug interactions that can be seen in patients receiving treatment for bacterial infections.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Healthcare resource utilization and costs associated with inadequate initial antibiotic treatment of bacteraemia produced by carbapenem-resistant Gram-negative bacilli (CRGNB): a descriptive, observational study in Spanish hospitals. [Relevancia de los polimorfismos genéticos en la neurotoxicidad por voriconazol: caso clínico en paciente pediátrico]. Living with dogs and cats: Is it a risk factor for community acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections in humans? [Whooping cough outbreak in 2024. New distribution pattern in contagion? Should the booster doses in vaccination be reconsidered?] Epidemiology of the COVID-19 pneumonia in a group of hospitals from Madrid -Spain during the full period of the State of Alarm- HM cohort.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1